Kirsimari Aaltonen
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
- Breast Cancer Treatment Studies 2
- Oncology top 10%
- Cancer-related Molecular Pathways 7
- HER2/EGFR in Cancer Research 2
- Genetics top 10%
- BRCA gene mutations in cancer 2
-
- DNA Repair Mechanisms 3
- Gene expression and cancer classification 2
- Toxicology top 10%
-
- Radiomics and Machine Learning in Medical Imaging 1
- Co-authors
- Heli NevanlinnaCarl BlomqvistPäivi HeikkiläKristiina AittomäkiRose‐Marie AminiAnitta TamminenTuomas HeikkinenOuti Kilpivaara
- Cited by
- Cancer ResearchOncologyGenetics
In The Last Decade
Kirsimari Aaltonen
16 papers receiving 823 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 240
- Oncology 333
- Genetics 233
- Molecular Biology 530
- Toxicology 26
Countries citing papers authored by Kirsimari Aaltonen
This map shows the geographic impact of Kirsimari Aaltonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsimari Aaltonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsimari Aaltonen more than expected).
Fields of papers citing papers by Kirsimari Aaltonen
This network shows the impact of papers produced by Kirsimari Aaltonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsimari Aaltonen. The network helps show where Kirsimari Aaltonen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kirsimari Aaltonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2018 | 2 | |
| 3 | 2017 | 2 | |
| 4 | 2012 | 17 | |
| 5 | 2009 | 94 | |
| 6 | 2009 | 98 | |
| 7 | 2008 | 31 | |
| 8 | 2008 | 126 | |
| 9 | 2008 | 54 | |
| 10 | 2008 | 161 | |
| 11 | 2008 | 16 | |
| 12 | 2007 | 57 | |
| 13 | 2007 | 63 | |
| 14 | 2007 | 89 | |
| 15 | 2006 | 22 | |
| 16 | 2004 | 2 |
About Kirsimari Aaltonen
Kirsimari Aaltonen is a scholar working on Cancer Research, Oncology and Toxicology, having authored 16 papers that have together received 835 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), DNA Repair Mechanisms (3 papers), Cancer Genomics and Diagnostics (3 papers), BRCA gene mutations in cancer (2 papers), Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Gene expression and cancer classification (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Cancer Research (240 citations), Oncology (333 citations) and Genetics (233 citations). Kirsimari Aaltonen has collaborated with scholars based in Finland, Sweden and China. Frequent co-authors include Heli Nevanlinna, Carl Blomqvist, Päivi Heikkilä, Kristiina Aittomäki, Rose‐Marie Amini, Anitta Tamminen, Tuomas Heikkinen, Outi Kilpivaara, Jiří Bártek and Jiřina Bártková. Their work appears in journals such as Nature Genetics, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.